Display options
Cite
Facheris MF, Hicks AA, Pramstaller PP, et al. Update on the management of restless legs syndrome: existing and emerging treatment options. Nat Sci Sleep. 2010;2:199-212doi: 10.2147/NSS.S6946.
Facheris, M. F., Hicks, A. A., Pramstaller, P. P., & Pichler, I. (2010). Update on the management of restless legs syndrome: existing and emerging treatment options. Nature and science of sleep, 2199-212. https://doi.org/10.2147/NSS.S6946
Facheris, Maurizio F, et al. "Update on the management of restless legs syndrome: existing and emerging treatment options." Nature and science of sleep vol. 2 (2010): 199-212. doi: https://doi.org/10.2147/NSS.S6946
Facheris MF, Hicks AA, Pramstaller PP, Pichler I. Update on the management of restless legs syndrome: existing and emerging treatment options. Nat Sci Sleep. 2010 Sep 08;2:199-212. doi: 10.2147/NSS.S6946. Print 2010. PMID: 23616710; PMCID: PMC3630948.
Copy Download .nbib Format: NLM
Share it on

Nat Sci Sleep. 2010 Sep 08;2:199-212. doi: 10.2147/NSS.S6946. Print 2010.

Update on the management of restless legs syndrome: existing and emerging treatment options.

Nature and science of sleep

Maurizio F Facheris, Andrew A Hicks, Peter P Pramstaller, Irene Pichler

Affiliations

  1. Institute of Genetic Medicine, European Academy Bozen/Bolzano (EURAC), Bolzano, Italy (Affiliated institute of the University of Lübeck, Lübeck, Germany) ; Department of Neurology, Central Hospital, Bolzano, Italy.

PMID: 23616710 PMCID: PMC3630948 DOI: 10.2147/NSS.S6946

Abstract

Restless legs syndrome (RLS) is a sensorimotor disorder, characterized by a circadian variation of symptoms involving an urge to move the limbs (usually the legs) as well as paresthesias. There is a primary (familial) and a secondary (acquired) form, which affects a wide variety of individuals, such as pregnant women, patients with end-stage renal disease, iron deficiency, rheumatic disease, and persons taking medications. The symptoms reflect a circadian fluctuation of dopamine in the substantia nigra. RLS patients have lower dopamine and iron levels in the substantia nigra and respond to both dopaminergic therapy and iron administration. Iron, as a cofactor of dopamine production and a regulator of the expression of dopamine type 2-receptor, has an important role in the RLS etiology. In the management of the disease, the first step is to investigate possible secondary causes and their treatment. Dopaminergic agents are considered as the first-line therapy for moderate to severe RLS. If dopaminergic drugs are contraindicated or not efficacious, or if symptoms are resistant and unremitting, gabapentin or other antiepileptic agents, benzodiazepines, or opioids can be used for RLS therapy. Undiagnosed, wrongly diagnosed, and untreated RLS is associated with a significant impairment of the quality of life.

Keywords: pathophysiology; quality of life

References

  1. Sleep. 2004 Jun 15;27(4):669-73 - PubMed
  2. Adv Neurol. 1984;40:159-70 - PubMed
  3. Arch Intern Med. 2004 Jan 26;164(2):196-202 - PubMed
  4. Neurology. 2003 Dec 9;61(11):1562-9 - PubMed
  5. Lancet Neurol. 2008 Jul;7(7):595-604 - PubMed
  6. Acta Med Scand. 1953;145(6):453-57 - PubMed
  7. J Neuropathol Exp Neurol. 2009 Nov;68(11):1193-9 - PubMed
  8. Brain. 2009 Sep;132(Pt 9):2403-12 - PubMed
  9. Sleep Med. 2010 Jan;11(1):31-7 - PubMed
  10. Brain. 2003 Jun;126(Pt 6):1485-92 - PubMed
  11. Funct Neurol. 1989 Jul-Sep;4(3):263-71 - PubMed
  12. Health Qual Life Outcomes. 2005 Dec 05;3:79 - PubMed
  13. Sleep Med. 2008 Jul;9(5):572-4 - PubMed
  14. Chest. 2006 Nov;130(5):1596-604 - PubMed
  15. Neurology. 2005 Jul 26;65(2):239-46 - PubMed
  16. J Gerontol A Biol Sci Med Sci. 2010 Feb;65(2):167-73 - PubMed
  17. Mov Disord. 1997 Jan;12(1):61-5 - PubMed
  18. Sleep Med. 2005 Jan;6(1):89 - PubMed
  19. Sleep Med. 2002 Nov;3 Suppl:S23-5 - PubMed
  20. Mayo Clin Proc. 2004 Jul;79(7):916-22 - PubMed
  21. Sleep Med. 2004 May;5(3):231-5 - PubMed
  22. Eur Neurol. 2000;43(2):70-5 - PubMed
  23. Sleep Med. 2005 Sep;6(5):407-13 - PubMed
  24. Acta Paediatr Scand. 1975 Mar;64(2):264-6 - PubMed
  25. Clin Neuropharmacol. 2008 Sep-Oct;31(5):281-6 - PubMed
  26. Acta Neurol Scand. 1984 Jun;69(6):428-30 - PubMed
  27. Mov Disord. 2006 Oct;21(10):1667-73 - PubMed
  28. Mov Disord. 2007 Oct 15;22(13):1912-6 - PubMed
  29. Sleep Med. 2002 Nov;3 Suppl:S35-42 - PubMed
  30. Sleep. 1992 Oct;15(5):391-5 - PubMed
  31. Value Health. 2005 Mar-Apr;8(2):157-67 - PubMed
  32. J Neurol. 2006 Aug;253 Suppl 4:IV22-8 - PubMed
  33. J Neurol Sci. 2010 Feb 15;289(1-2):135-7 - PubMed
  34. Am J Kidney Dis. 2001 Jul;38(1):104-8 - PubMed
  35. Sleep Med. 2003 Mar;4(2):101-19 - PubMed
  36. Pharmacol Biochem Behav. 2001 Jul-Aug;69(3-4):409-18 - PubMed
  37. Sleep Med. 2009 Jan;10(1):123-8 - PubMed
  38. N Engl J Med. 2003 May 22;348(21):2103-9 - PubMed
  39. Sleep Med. 2006 Oct;7(7):592-3 - PubMed
  40. Sleep Med. 2002 Jul;3(4):301-4 - PubMed
  41. Sleep. 2000 Aug 1;23(5):597-602 - PubMed
  42. Mov Disord. 2009 Jan 15;24(1):40-50 - PubMed
  43. Arch Intern Med. 2005 Jun 13;165(11):1286-92 - PubMed
  44. Sleep. 2004 May 1;27(3):560-83 - PubMed
  45. Neurology. 2005 Jun 14;64(11):1920-4 - PubMed
  46. Sleep Med Rev. 2009 Apr;13(2):149-56 - PubMed
  47. J Neuropsychiatry Clin Neurosci. 2008 Winter;20(1):101-5 - PubMed
  48. Nat Genet. 2008 Aug;40(8):946-8 - PubMed
  49. Br Med J. 1979 Mar 17;1(6165):751 - PubMed
  50. Sleep. 1999 Nov 1;22(7):970-99 - PubMed
  51. Sleep Med. 2006 Apr;7(3):263-8 - PubMed
  52. Neurology. 1999 Mar 23;52(5):932-7 - PubMed
  53. Neurology. 2006 Sep 12;67(5):900-1 - PubMed
  54. Am J Hum Genet. 2004 May;74(5):876-85 - PubMed
  55. Qual Life Res. 2004 Apr;13(3):679-93 - PubMed
  56. Nat Genet. 2007 Aug;39(8):1000-6 - PubMed
  57. Expert Opin Drug Metab Toxicol. 2008 May;4(5):655-64 - PubMed
  58. N Engl J Med. 2007 Aug 16;357(7):639-47 - PubMed
  59. Brain Res. 2006 Jan 27;1070(1):90-100 - PubMed
  60. Hum Mol Genet. 2009 Mar 15;18(6):1065-74 - PubMed
  61. Ann Neurol. 2005 Oct;58(4):630-4 - PubMed
  62. Sleep. 1999 Nov 1;22(7):961-8 - PubMed
  63. Sleep Med. 2008 Oct;9(7):715-26 - PubMed
  64. Sleep Med. 2009 Feb;10(2):206-11 - PubMed
  65. Neurology. 1996 Jan;46(1):92-5 - PubMed
  66. N Engl J Med. 2009 Mar 12;360(11):1155; author reply 1155-6 - PubMed
  67. Am J Kidney Dis. 2005 Feb;45(2):388-96 - PubMed
  68. J Pharmacol Exp Ther. 2002 Mar;300(3):932-8 - PubMed
  69. Mov Disord. 2005 Mar;20(3):345-8 - PubMed
  70. Sleep. 1993 Jun;16(4):327-32 - PubMed
  71. Expert Opin Pharmacother. 2009 Mar;10(4):545-54 - PubMed
  72. J Sleep Res. 2005 Mar;14(1):43-7 - PubMed
  73. Am J Hum Genet. 2001 Dec;69(6):1266-70 - PubMed
  74. Neurogenetics. 2008 May;9(2):75-82 - PubMed
  75. Am J Hum Genet. 2006 Oct;79(4):716-23 - PubMed
  76. Sleep Med. 2003 Mar;4(2):121-32 - PubMed
  77. Pediatrics. 2007 Aug;120(2):253-66 - PubMed
  78. Sleep Med. 2009 Oct;10(9):973-5 - PubMed
  79. Arq Neuropsiquiatr. 2008 Jun;66(2B):431-5 - PubMed
  80. J Neurol Sci. 1994 Sep;125(2):194-7 - PubMed
  81. Mov Disord. 2010 Jun 15;25(8):1019-25 - PubMed
  82. Clin Ther. 2004 Jun;26(6):925-35 - PubMed
  83. Neurosci Lett. 2004 Apr 29;360(3):161-4 - PubMed
  84. Pediatrics. 2003 Jan;111(1):e17-25 - PubMed
  85. Am J Med. 2007 Jan;120(1 Suppl 1):S22-7 - PubMed
  86. Neurology. 2000 Mar 14;54(5):1064-8 - PubMed
  87. Sleep Med. 2004 Jan;5(1):9-14 - PubMed
  88. Clin Neurophysiol. 2004 Sep;115(9):1975-88 - PubMed
  89. Sleep Med. 2000 Apr 1;1(2):163-167 - PubMed
  90. Sleep. 1998 Jun 15;21(4):371-7 - PubMed
  91. Mov Disord. 2008 Feb 15;23(3):350-8 - PubMed
  92. J Clin Pharm Ther. 2009 Oct;34(5):493-505 - PubMed
  93. CNS Drugs. 2008;22(6):497-518 - PubMed
  94. Biochemistry. 1987 Jun 16;26(12):3354-61 - PubMed
  95. Am J Med Genet B Neuropsychiatr Genet. 2010 Jan 5;153B(1):350-5 - PubMed
  96. J Neurol Neurosurg Psychiatry. 2002 Apr;72(4):555 - PubMed
  97. Sleep Med. 2004 Nov;5(6):561-5 - PubMed
  98. Sleep. 2008 Sep;31(9):1221-7 - PubMed
  99. Neurology. 2001 Jan 23;56(2):263-5 - PubMed
  100. Neuropeptides. 1988 May-Jun;11(4):181-4 - PubMed
  101. J Neurol. 2004 May;251(5):579-83 - PubMed
  102. CNS Drugs. 2010 Feb;24(2):89-98 - PubMed
  103. Psychiatry Clin Neurosci. 1997 Jun;51(3):103-7 - PubMed
  104. Sleep Med. 2005 Jul;6(4):307-12 - PubMed
  105. Sleep Med. 2001 May;2(3):239-242 - PubMed
  106. Mov Disord. 2009 Jul 30;24(10):1445-52 - PubMed
  107. Sleep Med Rev. 2010 Oct;14(5):339-46 - PubMed
  108. Sleep Med. 2010 May;11(5):494-6 - PubMed
  109. Sleep. 1996 Apr;19(3):205-13 - PubMed
  110. J Neurol. 2002 Feb;249(2):164-70 - PubMed
  111. J Neurol. 2010 Feb;257(2):230-7 - PubMed
  112. Mov Disord. 1998 May;13(3):566-9 - PubMed
  113. Sleep Med. 2006 Mar;7(2):175-83 - PubMed
  114. Ren Fail. 2004 Jul;26(4):393-7 - PubMed
  115. J Clin Neurophysiol. 2001 Mar;18(2):128-47 - PubMed
  116. J Neurol. 2001 Apr;248(4):311-4 - PubMed
  117. Sleep. 1986 Jun;9(2):370-1 - PubMed
  118. Sleep Med. 2000 Feb 1;1(1):11-19 - PubMed
  119. Lancet Neurol. 2006 Oct;5(10):878-86 - PubMed
  120. Sleep Med. 2005 Jul;6(4):301-5 - PubMed
  121. Mov Disord. 2001 Nov;16(6):1105-9 - PubMed
  122. Mov Disord. 2008 Dec 15;23(16):2267-302 - PubMed
  123. Neurology. 2000 Apr 25;54(8):1698-700 - PubMed
  124. Sleep. 1996 Apr;19(3):224-6 - PubMed
  125. Arch Intern Med. 2003 Oct 27;163(19):2323-9 - PubMed
  126. Sleep. 2005 Aug 1;28(8):1007-13 - PubMed
  127. Neurology. 1960 Sep;10:868-73 - PubMed
  128. Eur J Med Res. 2002 Aug 30;7(8):368-78 - PubMed
  129. J Neural Transm (Vienna). 2007 Jul;114(7):929-34 - PubMed
  130. Sleep Med. 2006 Jan;7(1):25-30 - PubMed
  131. Br Med J (Clin Res Ed). 1984 Feb 11;288(6415):444-6 - PubMed
  132. Neurology. 2003 Aug 12;61(3):304-9 - PubMed
  133. Neurology. 2000 Jan 25;54(2):502-4 - PubMed
  134. Sleep. 1986;9(3):385-92 - PubMed
  135. Semin Pediatr Neurol. 2008 Jun;15(2):91-9 - PubMed
  136. Sleep Med. 2008 Dec;9(8):874-81 - PubMed
  137. J Clin Psychiatry. 1999 Apr;60(4):241-4 - PubMed
  138. Sleep Med. 2009 Jun;10(6):611-5 - PubMed
  139. Mov Disord. 2006 Feb;21(2):258-63 - PubMed
  140. CNS Drugs. 2004;18(1):27-36 - PubMed
  141. Neurology. 2002 Nov 26;59(10):1573-9 - PubMed
  142. Mov Disord. 2001 May;16(3):577-9 - PubMed
  143. Neurology. 2008 Feb 26;70(9):686-94 - PubMed
  144. Sleep Med. 2004 May;5(3):237-46 - PubMed
  145. Mov Disord. 2007 Apr 15;22(5):627-31 - PubMed
  146. Mov Disord. 1998 Mar;13(2):324-9 - PubMed
  147. Neurology. 2009 Jul 21;73(3):243-5 - PubMed
  148. Age Ageing. 1994 May;23(3):200-3 - PubMed
  149. Curr Opin Neurol. 2005 Aug;18(4):405-10 - PubMed
  150. Acta Neurol Scand. 2007 May;115(5):347-50 - PubMed
  151. Mov Disord. 2007 Feb 15;22(3):424-7 - PubMed
  152. Eur J Clin Pharmacol. 1983;25(3):323-4 - PubMed
  153. Mov Disord. 2006 Apr;21(4):515-8 - PubMed
  154. Neurology. 2004 Mar 23;62(6):998-1000 - PubMed
  155. Transplant Proc. 2007 May;39(4):1132-3 - PubMed
  156. CNS Drugs. 2008;22(10):797-806 - PubMed

Publication Types